Alnylam Pharmaceuticals, Inc.ALNYNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Year-over-Year Change
Price-to-earnings ratio
Latest
166.04
↑ 1509% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-11.79
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 166.04 | +253.8% |
| 2024 | -107.99 | -98.8% |
| 2023 | -54.31 | -112.4% |
| 2022 | -25.57 | -8.5% |
| 2021 | -23.55 | -35.3% |
| 2020 | -17.41 | -22.6% |
| 2019 | -14.20 | -47.5% |
| 2018 | -9.63 | +58.9% |
| 2017 | -23.44 | -199.9% |
| 2016 | -7.81 | - |